Cargando…

Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study

BACKGROUND: The physical–functional and social–emotional health as well as survival of the elderly (≥75 years of age) haemodialysis patient is commonly thought to be poor. In a prospective, multicentre, non-interventional, observational study, the morbidity, mortality and quality of life (QoL) in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Seckinger, Joerg, Dschietzig, Wilfried, Leimenstoll, Gerd, Rob, Peter M, Kuhlmann, Martin K, Pommer, Wolfgang, Fraass, Uwe, Ritz, Eberhard, Schwenger, Vedat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5162412/
https://www.ncbi.nlm.nih.gov/pubmed/27994865
http://dx.doi.org/10.1093/ckj/sfw087
_version_ 1782482242546696192
author Seckinger, Joerg
Dschietzig, Wilfried
Leimenstoll, Gerd
Rob, Peter M
Kuhlmann, Martin K
Pommer, Wolfgang
Fraass, Uwe
Ritz, Eberhard
Schwenger, Vedat
author_facet Seckinger, Joerg
Dschietzig, Wilfried
Leimenstoll, Gerd
Rob, Peter M
Kuhlmann, Martin K
Pommer, Wolfgang
Fraass, Uwe
Ritz, Eberhard
Schwenger, Vedat
author_sort Seckinger, Joerg
collection PubMed
description BACKGROUND: The physical–functional and social–emotional health as well as survival of the elderly (≥75 years of age) haemodialysis patient is commonly thought to be poor. In a prospective, multicentre, non-interventional, observational study, the morbidity, mortality and quality of life (QoL) in this patient group were examined and compared with a younger cohort. METHODS: In 92 German dialysis centres, 2507 prevalent patients 19–98 years of age on haemodialysis for a median of 19.2 months were included in a drug monitoring study of darbepoetin alfa. To examine outcome and QoL parameters, 24 months of follow-up data in the age cohorts <75 and ≥75 years were analysed. Treatment parameters, adverse and intercurrent events, hospitalizations, morbidity and mortality were assessed. QoL was evaluated by means of the 47-item Functional Assessment of Chronic Illness Therapy–Anaemia score (FACT-An, version 4). RESULTS: The 2-year mortality rate was 34.7% for the older cohort and 15.8% for the younger cohort. The mortality rate for the haemodialysed elderly patients was 6.2% higher in absolute value compared with the age-matched background population. A powerful predictor of survival was the baseline FACT-An score and a close correlation with the 20-item anaemia subscale (AnS) was demonstrated. While the social QoL in the elderly patients was more stable than in the younger cohort (leading to equivalent values at the end of the study period), a pronounced deterioration of physical and functional status was observed. The median number of all-cause hospital days per patient-year was 12.3 for the elderly cohort and 8.9 for the younger patient population. The overall 24-month hospitalization rate was only marginally higher in the elderly cohort (34.0 versus 33.3%). CONCLUSIONS: In this observational study, the mortality rate of elderly haemodialysis patients was not exceedingly high compared with the age-matched background population. Furthermore, the hospitalization rate was only slightly higher compared with the younger age group and the median yearly hospitalization time trended lower compared with registry data. The social well-being of elderly haemodialysis patients showed a less pronounced decline over time and was equal to the score of the younger cohort at the end of the study period. The physical and functional status in the elderly patients was lower and showed a sharper decline over time. The baseline FACT-An score correlated closely with the 24-month survival probability.
format Online
Article
Text
id pubmed-5162412
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-51624122016-12-19 Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study Seckinger, Joerg Dschietzig, Wilfried Leimenstoll, Gerd Rob, Peter M Kuhlmann, Martin K Pommer, Wolfgang Fraass, Uwe Ritz, Eberhard Schwenger, Vedat Clin Kidney J Haemodialysis BACKGROUND: The physical–functional and social–emotional health as well as survival of the elderly (≥75 years of age) haemodialysis patient is commonly thought to be poor. In a prospective, multicentre, non-interventional, observational study, the morbidity, mortality and quality of life (QoL) in this patient group were examined and compared with a younger cohort. METHODS: In 92 German dialysis centres, 2507 prevalent patients 19–98 years of age on haemodialysis for a median of 19.2 months were included in a drug monitoring study of darbepoetin alfa. To examine outcome and QoL parameters, 24 months of follow-up data in the age cohorts <75 and ≥75 years were analysed. Treatment parameters, adverse and intercurrent events, hospitalizations, morbidity and mortality were assessed. QoL was evaluated by means of the 47-item Functional Assessment of Chronic Illness Therapy–Anaemia score (FACT-An, version 4). RESULTS: The 2-year mortality rate was 34.7% for the older cohort and 15.8% for the younger cohort. The mortality rate for the haemodialysed elderly patients was 6.2% higher in absolute value compared with the age-matched background population. A powerful predictor of survival was the baseline FACT-An score and a close correlation with the 20-item anaemia subscale (AnS) was demonstrated. While the social QoL in the elderly patients was more stable than in the younger cohort (leading to equivalent values at the end of the study period), a pronounced deterioration of physical and functional status was observed. The median number of all-cause hospital days per patient-year was 12.3 for the elderly cohort and 8.9 for the younger patient population. The overall 24-month hospitalization rate was only marginally higher in the elderly cohort (34.0 versus 33.3%). CONCLUSIONS: In this observational study, the mortality rate of elderly haemodialysis patients was not exceedingly high compared with the age-matched background population. Furthermore, the hospitalization rate was only slightly higher compared with the younger age group and the median yearly hospitalization time trended lower compared with registry data. The social well-being of elderly haemodialysis patients showed a less pronounced decline over time and was equal to the score of the younger cohort at the end of the study period. The physical and functional status in the elderly patients was lower and showed a sharper decline over time. The baseline FACT-An score correlated closely with the 24-month survival probability. Oxford University Press 2016-12 2016-09-26 /pmc/articles/PMC5162412/ /pubmed/27994865 http://dx.doi.org/10.1093/ckj/sfw087 Text en © The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Haemodialysis
Seckinger, Joerg
Dschietzig, Wilfried
Leimenstoll, Gerd
Rob, Peter M
Kuhlmann, Martin K
Pommer, Wolfgang
Fraass, Uwe
Ritz, Eberhard
Schwenger, Vedat
Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study
title Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study
title_full Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study
title_fullStr Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study
title_full_unstemmed Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study
title_short Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study
title_sort morbidity, mortality and quality of life in the ageing haemodialysis population: results from the elderly study
topic Haemodialysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5162412/
https://www.ncbi.nlm.nih.gov/pubmed/27994865
http://dx.doi.org/10.1093/ckj/sfw087
work_keys_str_mv AT seckingerjoerg morbiditymortalityandqualityoflifeintheageinghaemodialysispopulationresultsfromtheelderlystudy
AT dschietzigwilfried morbiditymortalityandqualityoflifeintheageinghaemodialysispopulationresultsfromtheelderlystudy
AT leimenstollgerd morbiditymortalityandqualityoflifeintheageinghaemodialysispopulationresultsfromtheelderlystudy
AT robpeterm morbiditymortalityandqualityoflifeintheageinghaemodialysispopulationresultsfromtheelderlystudy
AT kuhlmannmartink morbiditymortalityandqualityoflifeintheageinghaemodialysispopulationresultsfromtheelderlystudy
AT pommerwolfgang morbiditymortalityandqualityoflifeintheageinghaemodialysispopulationresultsfromtheelderlystudy
AT fraassuwe morbiditymortalityandqualityoflifeintheageinghaemodialysispopulationresultsfromtheelderlystudy
AT ritzeberhard morbiditymortalityandqualityoflifeintheageinghaemodialysispopulationresultsfromtheelderlystudy
AT schwengervedat morbiditymortalityandqualityoflifeintheageinghaemodialysispopulationresultsfromtheelderlystudy